Clinical Updates in ALL

 

Clinical Updates in ALL
13:46

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Management of Ph+ ALL in 2022

FEATURING Elias Jabbour
  • 113 views
  • October 13, 2022
  • 1
06:35

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Phase II Study of Blinatumomab in Combination With Ponatinib in Ph+ ALL - Updated Results

FEATURING Fadi Haddad
  • 70 views
  • October 13, 2022
12:49

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Approach to Ph-Like ALL

FEATURING Emily Curran
  • 24 views
  • October 13, 2022
09:08

Selina Luger

Approaches to and Use of MRD in ALL

  • 66 views
  • October 13, 2022
10:33

Lori Muffly

Next Questions: ALL

  • 132 views
  • October 14, 2022
  • 1
14:24

Jonathan Webster

2022 NCCN Guidelines Updates on MRD Testing in ALL

  • 149 views
  • September 21, 2022
  • 1
01:25

Jonathan Webster

Lecture Summary - 2022 NCCN Guidelines Updates on MRD Testing in ALL

  • 2 views
  • September 21, 2022
11:51

Emily Curran

Eliminating MRD in Adults With ALL Prior to Transplant: Practical Approaches and Unanswered Questions

  • 157 views
  • September 27, 2022
  • 1
10:21

Nicholas Short

Eliminating MRD Prior to HSCT in ALL: Strategies and Considerations

  • 168 views
  • September 27, 2022
  • 1
01:10

Nicholas Short

Lecture Summary - Eliminating MRD Prior to HSCT in ALL: Strategies and Considerations

  • 2 views
  • September 27, 2022
16:32

UChicago Medicine

Personalizing Therapeutic Approaches in Leukemia and Myeloid Malignancies

FEATURING Anand Patel
  • 186 views
  • August 19, 2022
13:56

Hagop Kantarjian

Adult ALL: Progress in Research and Therapy

  • 362 views
  • March 23, 2022
  • 2
06:01

ecancer

EHA 2022: Ponatinib & Blinatumomab for Patients With Ph+ ALL

FEATURING Nicholas Short
  • 142 views
  • June 24, 2022
  • 2
04:11

Total Health

ASCO 2022 Updates in Leukemia and MDS

FEATURING David Sallman
  • 1,087 views
  • August 9, 2022
  • 5
04:22

EHA 2022 Conference Coverage

EHA 2022 Tamibarotene in Combination With Ven & Aza in Previously Untreated Adult Pts Selected for RARA+ AML Who Are Ineligible for Standard Induction Therapy (SELECT-AML-1)

FEATURING Eytan Stein
  • 199 views
  • June 21, 2022
  • 2
06:42

ASCO 2022 Conference Coverage

ASCO 2022 Updates on the Evolution of Asparaginase in the Management of ALL

FEATURING Ryan Cassaday
  • 348 views
  • June 28, 2022
  • 1
56

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase in the Management of ALL

FEATURING Ryan Cassaday
  • 12 views
  • June 28, 2022
14:49

Penn Medicine Abramson Cancer Center

The Direction of Leukemia Treatment Nationally and Around the World: Ongoing and Upcoming Randomized Cooperative Group Trials

FEATURING Selina Luger
  • 321 views
  • May 4, 2022
  • 1
06:25

Hugo Akabane

ALL and Awareness Around MRD

  • 166 views
  • April 20, 2022
  • 4
16:32

Rachel Rau

Chemotherapy vs. Blinatumomab in R/R B-ALL

  • 310 views
  • April 1, 2022
24:40

ASH 2021 Conference Coverage on VuMedi

ASH 2021 Update on MRD in ALL: Standard of Care & Areas for Further Investigation

FEATURING Lori Muffly
  • 448 views
  • December 16, 2021
  • 3
15:51

Ryan Cassaday

MRD in Children and Young Adults With High-Risk ALL

  • 238 views
  • February 28, 2022
08:36

Elias Jabbour

Updates on Treatment Sequencing in ALL

  • 346 views
  • March 23, 2022
  • 6
11:32

SOHO 3rd Italian Conference

SOHO Italy 2021: Chemotherapy Free Regimens in Ph+ ALL

FEATURING Sabina Chiaretti
  • 113 views
  • January 5, 2022
13:29

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in ALL

FEATURING Bijal Shah
  • 208 views
  • October 1, 2021
13:15

SOHO 3rd Italian Conference

SOHO Italy 2021 on Triple Negative ALL: Past, Present, and Future

FEATURING Anna Ferrari
  • 60 views
  • December 23, 2021